$34.71
Last update: Sep 17, 4:16 AM

Market sentiment signals for Avalyn Pharma (AVLN): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$63
+80.6%
Highest Price Target
$80
+130.5%
Lowest Price Target
$51
+46.9%
Short Interest
4.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Morgan Stanley | Judah Frommer— | +64.2% | $53 → $57 | Maintained | Overweight |
| May 26, 2026 | Evercore ISI Group | Gavin Clark-Gartner— | +46.9% | $51 | Initiate | Outperform |